Mannatech (NASDAQ:MTEX) Coverage Initiated at StockNews.com

by · The Cerbat Gem

Analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a report issued on Wednesday. The firm set a “buy” rating on the stock.

Mannatech Price Performance

Shares of NASDAQ MTEX opened at $7.50 on Wednesday. The business’s fifty day simple moving average is $7.44 and its 200-day simple moving average is $7.63. Mannatech has a 12-month low of $6.75 and a 12-month high of $10.51. The company has a current ratio of 1.17, a quick ratio of 0.62 and a debt-to-equity ratio of 0.54.

Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. The company had revenue of $27.74 million during the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%.

Insiders Place Their Bets

In other news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction on Monday, September 9th. The shares were sold at an average price of $7.75, for a total value of $126,232.00. Following the sale, the director now directly owns 54,721 shares in the company, valued at approximately $424,087.75. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 41.50% of the stock is currently owned by company insiders.

About Mannatech

(Get Free Report)

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.

Recommended Stories